Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.53 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.53 |
| ▸ | TGM2 | P21980 | 1/20 | 0.52 |
| ▸ | RNASEL | Q05823 | 7/20 | 0.51 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.51 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.50 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.50 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.49 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.47 |
| ▸ | KRAS | P01116 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19186042 | 0.85 | RNASEL (0.69) | RNASEL | |
| SCHEMBL18937290 | 0.85 | RNASEL (0.69) | RNASEL | |
| SCHEMBL21648046 | 0.85 | TGM2 (0.61) | TAS1R3TAS1R1TGM2RNASELFUT5 | |
| SCHEMBL19448916 | 0.85 | TGM2 (0.61) | TAS1R3TAS1R1TGM2RNASELFUT5 | |
| SCHEMBL20324586 | 0.84 | RNASEL (0.60) | RNASELP2RY2P2RY4P2RY6 | |
| SCHEMBL21362202 | 0.84 | RNASEL (0.60) | TAS1R3TAS1R1TGM2RNASELFUT5 | |
| SCHEMBL22142885 | 0.83 | TGM2 (0.57) | TAS1R3TAS1R1TGM2RNASELFUT5 | |
| SCHEMBL20327568 | 0.82 | TAS1R3 (0.58) | TAS1R3TAS1R1TGM2RNASELFUT5 | |
| SCHEMBL23679554 | 0.82 | FUT5 (0.47) | TAS1R3TAS1R1TGM2FUT5P2RY2 | |
| SCHEMBL18937285 | 0.81 | FUT5 (0.55) | TAS1R3TAS1R1TGM2RNASELFUT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854799-B1 | CYCLIC DINUCLEOTIDE ANALOGUE, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION | SHANGHAI DE NOVO PHARMATECH CO LTD (CN) | 2024-07-17 | — | — | EP | disclosed |